Literature DB >> 25878124

Magnetic resonance imaging-based computational modelling of blood flow and nanomedicine deposition in patients with peripheral arterial disease.

Shaolie S Hossain1, Yongjie Zhang2, Xiaoyi Fu2, Gerd Brunner3, Jaykrishna Singh4, Thomas J R Hughes5, Dipan Shah6, Paolo Decuzzi7.   

Abstract

Peripheral arterial disease (PAD) is generally attributed to the progressive vascular accumulation of lipoproteins and circulating monocytes in the vessel walls leading to the formation of atherosclerotic plaques. This is known to be regulated by the local vascular geometry, haemodynamics and biophysical conditions. Here, an isogeometric analysis framework is proposed to analyse the blood flow and vascular deposition of circulating nanoparticles (NPs) into the superficial femoral artery (SFA) of a PAD patient. The local geometry of the blood vessel and the haemodynamic conditions are derived from magnetic resonance imaging (MRI), performed at baseline and at 24 months post intervention. A dramatic improvement in blood flow dynamics is observed post intervention. A 500% increase in peak flow rate is measured in vivo as a consequence of luminal enlargement. Furthermore, blood flow simulations reveal a 32% drop in the mean oscillatory shear index, indicating reduced disturbed flow post intervention. The same patient information (vascular geometry and blood flow) is used to predict in silico in a simulation of the vascular deposition of systemically injected nanomedicines. NPs, targeted to inflammatory vascular molecules including VCAM-1, E-selectin and ICAM-1, are predicted to preferentially accumulate near the stenosis in the baseline configuration, with VCAM-1 providing the highest accumulation (approx. 1.33 and 1.50 times higher concentration than that of ICAM-1 and E-selectin, respectively). Such selective deposition of NPs within the stenosis could be effectively used for the detection and treatment of plaques forming in the SFA. The presented MRI-based computational protocol can be used to analyse data from clinical trials to explore possible correlations between haemodynamics and disease progression in PAD patients, and potentially predict disease occurrence as well as the outcome of an intervention.
© 2015 The Author(s) Published by the Royal Society. All rights reserved.

Entities:  

Keywords:  atherosclerosis; finite-element modelling; magnetic resonance imaging; nanoparticles; vascular adhesion

Mesh:

Year:  2015        PMID: 25878124      PMCID: PMC4424675          DOI: 10.1098/rsif.2015.0001

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  49 in total

1.  Method for the calculation of velocity, rate of flow and viscous drag in arteries when the pressure gradient is known.

Authors:  J R WOMERSLEY
Journal:  J Physiol       Date:  1955-03-28       Impact factor: 5.182

2.  The effect of dynamic vessel motion on haemodynamic parameters in the right coronary artery: a combined MR and CFD study.

Authors:  R Torii; J Keegan; N B Wood; A W Dowsey; A D Hughes; G-Z Yang; D N Firmin; S A Mcg Thom; X Y Xu
Journal:  Br J Radiol       Date:  2009-01       Impact factor: 3.039

Review 3.  Discovery of the role of wall shear in atherosclerosis.

Authors:  C G Caro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-26       Impact factor: 8.311

4.  Geometry of the carotid bifurcation predicts its exposure to disturbed flow.

Authors:  Sang-Wook Lee; Luca Antiga; J David Spence; David A Steinman
Journal:  Stroke       Date:  2008-06-12       Impact factor: 7.914

5.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

6.  Patient-Specific Vascular NURBS Modeling for Isogeometric Analysis of Blood Flow.

Authors:  Yongjie Zhang; Yuri Bazilevs; Samrat Goswami; Chandrajit L Bajaj; Thomas J R Hughes
Journal:  Comput Methods Appl Mech Eng       Date:  2007-05-15       Impact factor: 6.756

7.  Hemodynamic analysis of a compliant femoral artery bifurcation model using a fluid structure interaction framework.

Authors:  Young-Ho Kim; Jong-Eun Kim; Yasushi Ito; Alan M Shih; Brigitta Brott; Andreas Anayiotos
Journal:  Ann Biomed Eng       Date:  2008-09-16       Impact factor: 3.934

8.  Choice of in vivo versus idealized velocity boundary conditions influences physiologically relevant flow patterns in a subject-specific simulation of flow in the human carotid bifurcation.

Authors:  Amanda K Wake; John N Oshinski; Allen R Tannenbaum; Don P Giddens
Journal:  J Biomech Eng       Date:  2009-02       Impact factor: 2.097

9.  Spatial regulation of inflammation by human aortic endothelial cells in a linear gradient of shear stress.

Authors:  Jean K Tsou; R Michael Gower; Harold J Ting; Ulrich Y Schaff; Michael F Insana; Anthony G Passerini; Scott I Simon
Journal:  Microcirculation       Date:  2008-05       Impact factor: 2.628

Review 10.  Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management.

Authors:  Alan B Lumsden; Terry W Rice; Changyi Chen; Wei Zhou; Peter H Lin; Paul Bray; Joel Morrisett; Vijay Nambi; Christie Ballantyne
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

View more
  9 in total

Review 1.  Manipulating nanoparticle transport within blood flow through external forces: an exemplar of mechanics in nanomedicine.

Authors:  Huilin Ye; Zhiqiang Shen; Le Yu; Mei Wei; Ying Li
Journal:  Proc Math Phys Eng Sci       Date:  2018-03-21       Impact factor: 2.704

Review 2.  Computational modeling and engineering in pediatric and congenital heart disease.

Authors:  Alison L Marsden; Jeffrey A Feinstein
Journal:  Curr Opin Pediatr       Date:  2015-10       Impact factor: 2.856

3.  Patient-Specific Flow Descriptors and Normalized wall index in Peripheral Artery Disease: a Preliminary Study.

Authors:  Jaykrishna Singh; Gerd Brunner; Joel D Morrisett; Christie M Ballantyne; Alan B Lumsden; Dipan J Shah; Paolo Decuzzi
Journal:  Comput Methods Biomech Biomed Eng Imaging Vis       Date:  2016-10-12

4.  Parameterization, geometric modeling, and isogeometric analysis of tricuspid valves.

Authors:  Emily L Johnson; Devin W Laurence; Fei Xu; Caroline E Crisp; Arshid Mir; Harold M Burkhart; Chung-Hao Lee; Ming-Chen Hsu
Journal:  Comput Methods Appl Mech Eng       Date:  2021-06-17       Impact factor: 6.588

Review 5.  The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.

Authors:  Nicholas DiStasio; Stephanie Lehoux; Ali Khademhosseini; Maryam Tabrizian
Journal:  Materials (Basel)       Date:  2018-05-08       Impact factor: 3.623

Review 6.  Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.

Authors:  Antonio Cervadoro; Roberto Palomba; Giuseppe Vergaro; Roberta Cecchi; Luca Menichetti; Paolo Decuzzi; Michele Emdin; Stefano Luin
Journal:  Front Bioeng Biotechnol       Date:  2018-11-27

Review 7.  The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Željko Reiner; Federico Carbone; Fabrizio Montecucco; Amirhossein Sahebkar
Journal:  Biomolecules       Date:  2019-08-26

8.  LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vulnerable atherosclerotic plaques.

Authors:  Jingxin Hou; Jun Zhou; Meiqi Chang; Guangcheng Bao; Jie Xu; Man Ye; Yixin Zhong; Shuling Liu; Junrui Wang; Wei Zhang; Haitao Ran; Zhigang Wang; Yu Chen; Dajing Guo
Journal:  Bioact Mater       Date:  2022-03-03

9.  Image-based patient-specific flow simulations are consistent with stroke in pediatric cerebrovascular disease.

Authors:  Shaolie S Hossain; Zbigniew Starosolski; Travis Sanders; Michael J Johnson; Michael C H Wu; Ming-Chen Hsu; Dianna M Milewicz; Ananth Annapragada
Journal:  Biomech Model Mechanobiol       Date:  2021-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.